Conjugation of proapoptotic peptides with folate and cyanine dyes for enhanced potency and selectivity towards tumor cell lines

16 September 2021, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


Despite continuous advances, anticancer therapy still faces several technical hurdles such as selectivity on cellular and subcellular targets of therapeutics. Toward addressing these limitations, we have combined the use of proapoptotic peptides, cyanine dyes and folate to target the mitochondria of tumor cells. Hence, a series of proapoptotic peptides and their conjugates with a cyanine dye and/or a folate were prepared via solid-phase peptide synthesis (SPPS) and their activity tested in different mammalian cell lines. Compounds bearing either a cyanine dye or folate were found to be more cytotoxic than the parent peptides or more selective towards cells overexpressing the folate receptor α, which is commonly found on the surface of tumor cells. Nevertheless, constructs containing both components showed diminished potency and selectivity.


cyanine dye
proapoptotic peptides
solid-phase peptide synthesis

Supplementary materials

Supporting Information
• SPPS procedures for compounds 3–15; TIC chromatograms of the crude of compound 3 synthesis before and after optimizing the SPPS protocol (Figure S1); TIC chromatogram of the crude for the synthesis of compound 10 after coupling folate to the ε-amino group of the N-terminal lysine. (Figure S2); TIC chromatogram of the crude of synthesis for compound 15 after coupling and deprotection of glutamic acid to the ε-amino group of the N-terminal lysine (Figure S3); characterization data for compounds 3–15 (Table S1 + Figure S4–S16); cytotoxicity data (Figure S17–S19). (PDF)


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.